Dr. Madeline King received a bachelors degree in Biology from the University of Texas (Austin, TX) and doctor of pharmacy degree from Texas A&M University (College Station, TX). She then completed a PGY1 pharmacy practice residency at NewYork Presbyterian Hospital (New York, NY) and a PGY2 infectious diseases pharmacy residency at Temple University School of Pharmacy (Philadelphia, PA). She is a board-certified infectious diseases pharmacist.
Dr. King is currently an assistant professor of clinical pharmacy at the Philadelphia College of Pharmacy (Philadelphia, PA) and practices as an infectious diseases clinical pharmacist at Cooper University Hospital (Camden, NJ) where she precepts 4th year pharmacy students on infectious diseases rotations. She also takes students to Guatemala as part of a public and global health rotation.
Dr. King spends time teaching the infectious diseases fellows at Cooper, and teaching antimicrobial pharmacology to medical students. Her research has been in treating multi-drug resistant organisms and has published a multi-center case series on outcomes with ceftazidime-avibactam.
ARTICLES
